alpha glucosidase/비만증

This invention relates to novel 1,4-di-deoxy-1,4-imino-D-arabinitol derivatives, to the processes for their preparation and to their end-use applications, particularly as to their use in the treatment of diabetes. More specifically this invention relates to novel N-glycosyl derivatives of

BACKGROUND Glucosidase enzymes are involved in several biological processes such as the intestinal digestion, the biosynthesis of glycoproteins and the lysosomal catabolism of the glycoconjugates (Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of

OBJECTS OF THE INVENTION It is an object of the invention to control weight in humans by ingesting acarbose with meals with food containing carbohydrates. This and other objects and advantages will become obvious from the following detailed description. THE INVENTION The invention is directed to a

This invention pertains to the use of maltosyl-isomaltooligosaccharides as a dietary supplement for birds and mammals, specifically, to promote the growth of beneficial intestinal microbes, inhibit the growth of pathogenic intestinal microbes, and for therapeutic intervention in diseases such as

This invention pertains to the use of maltosyl-isomaltooligosaccharides as a dietary supplement for birds and mammals, specifically, to promote the growth of beneficial intestinal microbes, inhibit the growth of pathogenic intestinal microbes, and for therapeutic intervention in diseases such as

This invention relates to a novel inosose compound represented by the general formula: ##STR3## wherein X.sup.1 and X.sup.2 are both halogen, X.sup.1 is hydrogen and X.sup.2 is halogen, or X.sup.1 is --SQ.sup.1 and X.sup.2 is --SQ.sup.2 (each of Q.sup.1 and Q.sup.2 is lower alkyl or Q.sup.1 and

This invention relates to a novel inosose compound represented by the general formula: ##STR3## wherein X.sup.1 and X.sup.2 are both halogen, X.sup.1 is hydrogen and X.sup.2 is halogen, or X.sup.1 is --SQ.sup.1 and X.sup.2 is --SQ.sup.2 (each of Q.sup.1 and Q.sup.2 is lower alkyl or Q.sup.1 and

FIELD OF INVENTION In general, the present invention relates to pharmaceutical compositions, and more particularly, to pharmaceutical compositions for the treatment of diabetes mellitus using combination therapy. BACKGROUND OF THE INVENTION Diabetes mellitus is a term generally used to refer to

FIELD OF INVENTION In general, the present invention relates to pharmaceutical compositions, and more particularly, to pharmaceutical compositions for the treatment of diabetes mellitus using combination therapy. BACKGROUND OF THE INVENTION Diabetes mellitus is a term generally used to refer to

FIELD OF INVENTION In general, the present invention relates to pharmaceutical compositions, and more particularly, to pharmaceutical compositions for the treatment of diabetes mellitus using combination therapy. BACKGROUND OF THE INVENTION Diabetes mellitus is a term generally used to refer to